Cytoplasmic nucleophosmin (cNPM) in acute myeloid leukaemia: Relation to disease characteristicsFootnote

Available online 26 August 2011

Footnote

Peer review under responsibility of Alexandria University Faculty of Medicine

References

• D.G.GillilandC.T.JordanC.A.FelixThe molecular basis of leukemiaHematology (Am Soc Hematol Educ Program)20048097
   PubMedGoogle Scholar
• E.JaffeN.HarrisH.SteinJ.VardimanPathology and genetics of tumours of hematopoietic and lymphoid tissues2001IARC PressLyon, France
   Google Scholar
• D.GrimwadeH.WalkerF.OliverThe importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial: The Medical Research Council Adult and Children's Leukaemia Working PartiesBlood92199823222333
   PubMed Web of Science ®Google Scholar
• G.MarcucciK.MrozekC.D.BloomfieldMolecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogeneticsCurr Opin Hematol1220056875
   PubMed Web of Science ®Google Scholar
• L.BullingerK.DohnerE.BairUse of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemiaN Engl J Med350200416051616
   PubMed Web of Science ®Google Scholar
• P.J.ValkR.G.VerhaakM.A.BeijenPrognostically useful gene-expression profiles in acute myeloid leukemiaN Engl J Med350200416171628
   PubMed Web of Science ®Google Scholar
• C.RoumierP.FenauxM.LafageM.ImbertV.EclacheC.PreudhommeNew mechanisms of AML1 gene alteration in hematological malignanciesLeukemia172003916
   PubMed Web of Science ®Google Scholar
• T.PabstB.U.MuellerP.ZhangDominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemiaNat Genet272001263270
   PubMed Web of Science ®Google Scholar
• S.FrohlingR.F.SchlenkI.StolzeCEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutationsJ Clin Oncol222004624633
   PubMed Web of Science ®Google Scholar
• H.LeroyC.RoumierP.HuygheV.BiggioP.FenauxC.PreudhommeCEBPA point mutations in hematological malignanciesLeukemia192005329334
   PubMed Web of Science ®Google Scholar
• S.SchnittgerC.SchochM.DugasAnalysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual diseaseBlood10020025966
   PubMed Web of Science ®Google Scholar
• C.ThiedeC.SteudelB.MohrAnalysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosisBlood99200243264335
   PubMed Web of Science ®Google Scholar
• A.BeghiniC.B.RipamontiR.CairoliKIT activating mutations: incidence in adult and pediatric acute myeloid leukemia, and identification of an internal tandem duplicationHaematologica892004920925
   PubMed Web of Science ®Google Scholar
• H.KiyoiT.NaoeY.NakanoPrognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemiaBlood93199930743080
   PubMed Web of Science ®Google Scholar
• S.SchnittgerU.KinkelinC.SchochScreening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AMLLeukemia142000796804
   PubMed Web of Science ®Google Scholar
• K.DohnerK.TobisR.UlrichPrognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group UlmJ Clin Oncol20200232543261
   PubMed Web of Science ®Google Scholar
• C.SteudelM.WermkeM.SchaichComparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemiaGenes Chromosomes Cancer372003237251
   PubMed Web of Science ®Google Scholar
• B.FaliniC.MecucciE.TiacciCytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotypeN Engl J Med3522005254266
   PubMed Web of Science ®Google Scholar
• J.L.CordellK.A.PulfordB.BigernaDetection of normal and chimeric nucleophosmin in human cellsBlood931999632642
   PubMed Web of Science ®Google Scholar
• J.S.AndersenY.W.LamA.K.LeungNucleolar proteome dynamicsNature43320057783
   PubMed Web of Science ®Google Scholar
• Y.W.LamL.Trinkle-MulcahyA.I.LamondThe nucleolusJ Cell Sci118200513351337
   PubMed Web of Science ®Google Scholar
• D.L.SpectorR.L.OchsH.BuschSilver staining, immunofluorescence, and immunoelectron microscopic localization of nucleolar phosphoproteins B23 and C23Chromosoma901984139148
   PubMed Web of Science ®Google Scholar
• R.A.BorerC.F.LehnerH.M.EppenbergerE.A.NiggMajor nucleolar proteins shuttle between nucleus and cytoplasmCell561989379390
   PubMed Web of Science ®Google Scholar
• J.P.YunE.C.ChewC.T.LiewNucleophosmin/B23 is a proliferate shuttle protein associated with nuclear matrixJ Cell Biochem90200311401148
   PubMed Web of Science ®Google Scholar
• Y.YuL.B.MaggiJr.S.N.BradyNucleophosmin is essential for ribosomal protein L5 nuclear exportMol Cell Biol26200637983809
   PubMed Web of Science ®Google Scholar
• W.WangA.BudhuM.ForguesX.W.WangTemporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplicationNat Cell Biol72005823830
   PubMed Web of Science ®Google Scholar
• J.H.ChangM.O.OlsonStructure of the gene for rat nucleolar protein B23J Biol Chem26519901822718233
   PubMedGoogle Scholar
• D.WangH.UmekawaM.O.OlsonExpression and subcellular locations of two forms of nucleolar protein B23 in rat tissues and cellsCell Mol Biol Res3919933342
   Google Scholar
• D.GrimwadeNPM1 mutation in AML: who and why?Blood10820063965
   Web of Science ®Google Scholar
• B.FaliniI.NicolettiM.F.MartelliC.MecucciAcute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical featuresBlood1092007874885
   PubMed Web of Science ®Google Scholar
• RachelRauPatrickBrownNucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukemia: towards definition of a new leukemia entityHematol Oncol2742009171181
   Web of Science ®Google Scholar
• E.AmmatunaN.I.NogueraD.ZangrilliRapid detection of nucleophosmin (NPM1) mutations in acute myeloid leukemia by denaturing HPLCClin Chem51200521652167
   PubMed Web of Science ®Google Scholar
• G.RotiR.RosatiR.BonassoDenaturing high-performance liquid chromatography: a valid approach for identifying NPM1 mutations in acute myeloid leukemiaJ Mol Diagn82006254259
   PubMed Web of Science ®Google Scholar
• N.I.NogueraE.AmmatunaD.ZangrilliSimultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemiaLeukemia19200514791482
   PubMed Web of Science ®Google Scholar
• L.I.LinT.C.LinW.C.ChouJ.L.TangD.T.LinH.F.TienA novel fluorescence-based multiplex PCR assay for rapid simultaneous detection of CEBPA mutations and NPM mutations in patients with acute myeloid leukemiasLeukemia20200618991903
   PubMed Web of Science ®Google Scholar
• B.FaliniM.P.MartelliN.BolliImmunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemiaBlood108200619992005
   PubMed Web of Science ®Google Scholar
• N.BolliS.GalimbertiM.P.MartelliCytoplasmic nucleophosmin in myeloid sarcoma occurring 20 years after diagnosis of acute myeloid leukaemiaLancet Oncol72006350352
   PubMed Web of Science ®Google Scholar
• B.J.BainS.M.LewisPreparation and staining methods for blood and bone marrow filmsS.LewisB.BainI.Bates10th ed.Practical hematologyvol. 42006Churchill Livingstone6076
   Google Scholar
• I.BatesBone marrow biopsyS.LewisB.BainI.Bates10th ed.Practical hematologyvol. 62006Churchill Livingstone116130
   Google Scholar
• D.SwirskyB.J.BainErythrocyte and leukocyte cytochemistryS.LewisB.BainI.Bates10th ed.Practical hematologyvol. 132006Churchill Livingstone311334
   Google Scholar
• P.H.WiernickDiagnosis and treatment of adult acute myelocytic leukemiaP.H.WiernickG.P.CanellosJ.P.DutcherR.A.KyleNeoplastic disease of the blood1996Churchill LivingstoneNew York331351
   Google Scholar
• A.R.HandersonD.W.MossEnzymesC.A.BurtisE.R.Ashwood5th ed.Tietz fundamentals of clinical chemistryvol. 12001WB SaundersLubbock, TX352389
   Google Scholar
• D.J.NewmanC.P.PriceNonprotein nitrogen metabolitesC.A.BurtisE.R.Ashwood5th ed.Tietz fundamentals of clinical chemistryvol. 12001WB SaundersLubbock, TX414426
   Google Scholar
• K.M.GustashawChromosome stainsM.J.BarchThe ACT cytogenetics laboratory manual. The Association of Cytogenetic Technologists2nd ed.1991Raven Press Ltd.New York
   Google Scholar
• G.KingS.PayneF.WalkerG.I.MurrayA highly sensitive detection method for immunohistochemistry using biotinylated tyramineJ Pathol1831997237241
   PubMed Web of Science ®Google Scholar
• B.FaliniI.NicolettiN.BolliM.P.MartelliA.LisoP.GorelloTranslocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemiasHaematologica9242007519532
   PubMed Web of Science ®Google Scholar
• B.FaliniN.BolliA.LisoM.P.MartelliR.MannucciS.PileriAltered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implicationsLeukemia2310200917311743
   PubMed Web of Science ®Google Scholar
• J.LuoC.QiW.XuS.Kamel-ReidJ.BrandweinH.ChangCytoplasmic expression of nucleophosmin accurately predicts mutation in the nucleophosmin gene in patients with acute myeloid leukemia and normal karyotypeAm J Clin Pathol133120103440
   Web of Science ®Google Scholar
• S.KonoplevX.HuangH.A.DrabkinCytoplasmic localization of nucleophosmin in bone marrow blasts of acute myeloid leukemia patients is not completely concordant with NPM1 mutation and is not predictive of prognosisCancer11520200947374744
   Web of Science ®Google Scholar
• K.DohnerR.F.SchlenkM.HabdankC.SchollF.G.RuckerA.CorbaciogluMutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutationsBlood106200537403746
   PubMed Web of Science ®Google Scholar
• S.SchnittgerC.SchochW.KernC.MecucciC.TschulikM.F.MartelliNucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotypeBlood106200537333739
   PubMed Web of Science ®Google Scholar
• G.ZiniG.d’OnofrioEpitaph for erythroleukaemiaHaematologica8962004e82
   Google Scholar
• R.G.VerhaakC.S.GoudswaardW.van PuttenMutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significanceBlood106200537473754
   PubMed Web of Science ®Google Scholar
• M.P.MartelliV.PettirossiC.ThiedeCD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised miceBlood11619201039073922
   PubMed Web of Science ®Google Scholar
• D.C.TaussigJ.VargaftigF.Miraki-MoudLeukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34− fractionBlood11510201019761984
   PubMed Web of Science ®Google Scholar
• T.R.KauJ.C.WayP.A.SilverNuclear transport and cancer: from mechanism to interventionNat Rev Cancer42004106117
   PubMed Web of Science ®Google Scholar
• S.GrisendiC.MecucciB.FaliniP.P.PandolfiNucleophosmin and cancerNat Rev Cancer62006493505
   PubMed Web of Science ®Google Scholar
• I.H.HollinkC.M.ZwaanM.ZimmermannFavorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AMLLeukemia232008262
   Web of Science ®Google Scholar
• ChetsadaBoonthimatWannaThongnoppakhunChirayu U.AuewarakulNucleophosmin mutation in Southeast Asian acute myeloid leukemia: eight novel variants, FLT3 coexistence and prognostic impact of NPM1/FLT3 mutationsHaematologica9310200815651569https://doi.org/10.3324/haematol.12937
   Web of Science ®Google Scholar